This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery

This study has been completed.
Information provided by:
Abbott Identifier:
First received: November 26, 2006
Last updated: January 14, 2011
Last verified: January 2011
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of Extended Release Hydrocodone/Acetaminophen with placebo over a 48 hour dosing period in patients who have had bunionectomy surgery, and to assess the safety of the drug for 7 days after patients are discharged from the hospital.

Condition Intervention Phase
Pain Drug: Hydrocodone/Acetaminophen Extended Release Drug: Placebo Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study Comparing the Analgesic Activity of Hydrocodone/Acetaminophen Extended Release and Placebo in Subjects With Pain Following Bunionectomy Surgery

Resource links provided by NLM:

Further study details as provided by Abbott:

Primary Outcome Measures:
  • Time-interval-weighted sum of pain relief (TOTPAR)score for 0 to 12 hours following the first dose of study drug administration [ Time Frame: 12 hours ]
    Pain relief measured by a 100mm Visual Analog Scale (VAS)

Secondary Outcome Measures:
  • Time interval weighted sum of pain intensity difference (SPID)scores [ Time Frame: 12 hours ]
    Sum of pain intensity difference

Enrollment: 210
Study Start Date: October 2003
Study Completion Date: March 2004
Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Arm 1: hydrocodone/acetaminophen extended release Drug: Hydrocodone/Acetaminophen Extended Release
1 tablet every 12 hours
Other Name: ABT-712
Experimental: Arm 2: hydrocodone/acetaminophen extended release Drug: Hydrocodone/Acetaminophen Extended Release
2 tablets every 12 hours
Other Name: ABT-712
Placebo Comparator: placebo Drug: Placebo
2 tablets every 12 hours


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Male or female ages 18 to 65
  • Females must be of non-childbearing potential or practicing birth control
  • Subject is scheduled to undergo primary, unilateral first metatarsal bunionectomy surgery

Exclusion Criteria:

  • Is allergic to or has a serious reaction to hydrocodone, or other opioids, acetaminophen, lidocaine or propofol, and/or similar drugs
  • Has initiated corticosteroid therapy within the past month or is scheduled to receive any corticosteroid during the study
  • Is associated with any currently ongoing research study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00404391

United States, Maryland
Site Ref # / Investigator 4993
Owing Mills, Maryland, United States, 21117
United States, Texas
Site Ref # / Investigator 4994
Austin, Texas, United States, 78705
Site Ref # / Investigator 4992
San Marcos, Texas, United States, 78666
United States, Utah
Site Ref # / Investigator 4995
Salt Lake City, Utah, United States, 84117
Sponsors and Collaborators
Study Director: Rita Jain, MD Abbott
  More Information

Responsible Party: Victor Jorden, MD, Abbott Identifier: NCT00404391     History of Changes
Other Study ID Numbers: M03-609
Study First Received: November 26, 2006
Last Updated: January 14, 2011

Keywords provided by Abbott:
Moderate to severe pain following bunionectomy surgery

Additional relevant MeSH terms:
Acetaminophen, hydrocodone drug combination
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Analgesics, Opioid
Central Nervous System Depressants
Antitussive Agents
Respiratory System Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Inflammatory Agents
Antirheumatic Agents processed this record on August 17, 2017